Export 9 results:
Author Title [ Type(Asc)] Year
Filters: Author is Torrado, E.  [Clear All Filters]
Journal Article
Moreira-Teixeira, L., Sousa, J., McNab, F. W., Torrado, E., et al. (2016). Type i IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-γ signaling. Journal of Immunology, 197(12), 4714 - 4726.
Vilanova, M., Teixeira, L., Caramalho, Í., Torrado, E., et al. (2004). Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology, 111(3), 334 - 342.
Fraga, A. G., Cruz, A., Martins, T. G., Torrado, E., et al. (2011). Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression. Infection and Immunity, 79(1), 421 - 430.
Oliveira, M. S., Fraga, A. G., Torrado, E., Castro, A. G., et al. (2005). Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice. Infection and Immunity, 73(10), 6299 - 6310.
Cunha, C., Gonçalves, S. M., Duarte-Oliveira, C., Leite, L., et al. (2017). IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. Journal of Allergy and Clinical Immunology, 140(3), 867 - 870.e9.
Portaels, F., Meyers, W. M., Ablordey, A., Castro, A. G., et al. (2008). First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Neglected Tropical Diseases, 2(3).
Torrado, E., Fraga, A. G., Castro, A. G., Stragier, P., et al. (2007). Evidence for an intramacrophage growth phase of Mycobacterium ulcerans. Infection and Immunity, 75(2), 977 - 987.
Fraga, A. G., Martins, T. G., Torrado, E., Huygen, K., et al. (2012). Cellular immunity confers transient protection in experimental buruli ulcer following BCG or mycolactone-negative mycobacterium ulcerans vaccination. PLoS ONE, 7(3).
Cruz, A., Torrado, E., Carmona, J., Fraga, A. G., et al. (2015). BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells. Vaccine, 33(1), 85 - 91.

Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc